Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a new MedlinePlus Genetics topic on Ovarian cancer and updated to v3.0.2; removed the 'Back to Top' link.SummaryDifference0.4%
- Check11 days agoChange DetectedThe page has been updated to version 3.0.1, and the section on ovarian cancer related to MedlinePlus Genetics has been removed.SummaryDifference0.4%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, specifically changing the reference to Washington D.C. and adding new scientific terms related to proteins and cancer treatment.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.